May 21, 2020 / 7:26 AM / 14 days ago

BRIEF-Glaxosmithkline Pharmaceuticals To Discontinue Supply Of Ranitidine Products

May 21 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd :

* TO DISCONTINUE MANUFACTURE AND SUPPLY OF ZINETAC TABLETS

* WILL REQUEST CANCELLATION OF MARKETING AUTHORIZATION(S) ASSOCIATED WITH ZINETAC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below